Identifying sensitive measures of cognitive decline at different clinical stages of Alzheimer’s disease

OBJECTIVE: Alzheimer’s disease (AD) studies are increasingly targeting earlier (pre)clinical populations, in which the expected degree of observable cognitive decline over a certain time-interval is reduced as compared to the dementia stage. Consequently, endpoints to capture early cognitive changes...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Int Neuropsychol Soc
Hlavní autoři: Jutten, Roos J., Sikkes, Sietske A.M., Amariglio, Rebecca E., Buckley, Rachel F., Properzi, Michael J., Marshall, Gad A., Rentz, Dorene M., Johnson, Keith A., Teunissen, Charlotte E., Van Berckel, Bart N.M., Van der Flier, Wiesje M., Scheltens, Philip, Sperling, Reisa A., Papp, Kathryn V.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8041916/
https://ncbi.nlm.nih.gov/pubmed/33046162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1355617720000934
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky